Pensees
Founded 2015 · 6 employees on LinkedIn · 2 known investors
Pensees develops cultivated meat produced by growing animal cells, using its patented 3D bioprinting technology. The company positions cultivated meat as a sustainable alternative for meat production.
Also known as ㈜팡세 · Pensées · Pensées Inc. · 팡세
Investors · 2
Company profile
researched Aug 2026Pensées Inc. (㈜팡세) is a South Korean company that produces cultivated meat grown from animal cells using 3D bioprinting technology it has patented. Established in 2015, the company began with the development of a 3D bioprinting device and subsequently developed homogeneous-quality cancer cell structures (cancer spheroids) and liver and brain organ analogue (organoid) models.
Since 2021 the company has operated as a food tech startup, extending its 3D bioprinting technology to the research and development of cultivated meat with a textured, meat-like eating quality. Its current development work centers on extracting and cultivating bovine muscle cells to produce edible, textured cultivated meat. The company frames cultivated meat as a means of producing meat sustainably.
Founding story
Pensées Inc. was established in 2015 around the development of a 3D bioprinting device, opening an R&D center in 2016 and launching its Vitarix 3D bio printer in 2017. After releasing a second-generation printer (Vitarix W) and a ready-to-use cancer spheroid product in 2020, the company pivoted in 2021 to applying its bioprinting technology to cultivated meat.
Traction
The company held a cultivated meat tasting event in 2022 and had previously commercialized 3D bioprinting hardware and a ready-to-use cancer spheroid product.
Latest developments
The company states it continues to focus on research and development of edible, textured cultivated meat produced by extracting and cultivating bovine muscle cells.
▸Full profile — technology, geography, history
Technology
The company's core technology is patented 3D bioprinting, originally applied to bioprinting devices (Vitarix and Vitarix W), cancer spheroids of homogeneous quality, and liver and brain organoid models. Since 2021 this technology has been applied to growing and structuring bovine muscle cells into cultivated meat intended to have a textured mouthfeel.
Geography
Headquartered in South Korea; the website is published in Korean and English.
History
Milestones stated by the company: 2015 incorporation; 2016 establishment of an R&D center; 2017 launch of the Vitarix 3D Bio Printer (Ver.1); 2020 launch of the Vitarix W 3D Bio Printer (Ver.2) and a Ready-To-Use Cancer Spheroid product; 2021 pivot to cultivated meat; 2022 cultivated meat tasting event.
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
Timeline · 7
launches, deals, and filingsThe company expanded the scope of its patented 3D bioprinting technology and began research and development of cultivated meat.
Pensées Inc. was established, starting with the development of a 3D bioprinting device.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 5
primary sources listed
- Penseespensees.co.kr · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Pensees do?
- South Korean food tech company developing cultivated meat from bovine cells using patented 3D bioprinting technology.
- Who are Pensees's investors?
- Pensees's investors include Ascendo Ventures, Lotte Ventures.